Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 分子醫學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99945
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor李妮鍾zh_TW
dc.contributor.advisorNi-Chung Leeen
dc.contributor.author張書蓉zh_TW
dc.contributor.authorShu-Jung Changen
dc.date.accessioned2025-09-22T16:05:48Z-
dc.date.available2025-09-23-
dc.date.copyright2025-09-22-
dc.date.issued2025-
dc.date.submitted2025-07-24-
dc.identifier.citation英文參考文獻
Ajufo, E., DeGoma, E. M., Raper, A., Yu, K. D., Cuchel, M., & Rader, D. J. (2021). A randomized controlled trial of genetic testing and cascade screening in familial hypercholesterolemia. Genetics in Medicine, 23(9), 1697-1704.
Axelsson, M. (2013). Report on personality and adherence to antibiotic therapy: a population-based study. BMC psychology, 1, 1-6.
Baldry, E., Redlinger‐Grosse, K., MacFarlane, I., Walters, S. T., Ash, E., Steinberger, J., ... & Zierhut, H. (2022). Outcomes from a pilot genetic counseling intervention using motivational interviewing and the extended parallel process model to increase cascade cholesterol screening. Journal of Genetic Counseling, 31(1), 164-175.
Baumeister, R. F., & Vohs, K. D. (2007). Self‐Regulation, ego depletion, and motivation. Social and personality psychology compass, 1(1), 115-128.
Bogg, T., & Roberts, B. W. (2004). Conscientiousness and health-related behaviors: a meta-analysis of the leading behavioral contributors to mortality. Psychological bulletin, 130(6), 887.
Casula, M., Scotti, L., Tragni, E., Merlino, L., Corrao, G., & Catapano, A. L. (2016). Drug treatment and adherence of subjects< 40 years with diagnosis of heterozygous familial hypercholesterolemia. Atherosclerosis, 254, 172-178.
Costa, P. T., & McCrae, R. R. (1999). A five-factor theory of personality. Handbook of personality: Theory and research, 2(01), 1999.
de la Fuente, J., Sander, P., Umerenkova, A. G., Urien, B., Pachón-Basallo, M., & Luis, E. O. (2024). The big five factors as differential predictors of self-regulation, achievement emotions, coping and health behavior in undergraduate students. BMC psychology, 12, 267.
Defesche, J. C., Gidding, S. S., Harada-Shiba, M., Hegele, R. A., Santos, R. D., & Wierzbicki, A. S. (2017). Familial hypercholesterolaemia. Nature reviews Disease primers, 3(1), 1-20.
Degoma, E. M., Ahmad, Z. S., O’Brien, E. C., Kindt, I., Shrader, P., Newman, C. B.,…Hudgins, L. C. (2016). Treatment gaps in adults with heterozygous familial hypercholesterolemia in the United States: data from the CASCADE-FH registry. Circulation: Cardiovascular Genetics, 9(3), 240-249.
Fahed, A. C., Wang, M., Patel, A. P., Ajufo, E., Maamari, D. J., Aragam, K. G.,…Ng, K. (2022). Association of the interaction between familial hypercholesterolemia variants and adherence to a healthy lifestyle with risk of coronary artery disease. JAMA network open, 5(3), e222687-e222687.
Fu, M. R., Kurnat-Thoma, E., Starkweather, A., Henderson, W. A., Cashion, A. K., Williams, J. K.,…de Mendoza, V. B. (2020). Precision health: A nursing perspective. International journal of nursing sciences, 7(1), 5-12.
Gambhir, S. S., Ge, T. J., Vermesh, O., & Spitler, R. (2018). Toward achieving precision health. Science translational medicine, 10(430), eaao3612.
Hagger, M. S., Hardcastle, S. J., Hingley, C., Strickland, E., Pang, J., & Watts, G. F. (2016). Predicting self-management behaviors in familial hypercholesterolemia using an integrated theoretical model: the impact of beliefs about illnesses and beliefs about behaviors. International Journal of Behavioral Medicine, 23, 282-294.
Hagger, M. S., Hardcastle, S. J., Hu, M., Kwok, S., Lin, J., Nawawi, H. M., ... & Watts, G. F. (2018). Health literacy in familial hypercholesterolemia: A cross-national study. European journal of preventive cardiology, 25(9), 936-943.
Hampson, S. E., Edmonds, G. W., Barckley, M., Goldberg, L. R., Dubanoski, J. P., & Hillier, T. A. (2016). A Big Five approach to self-regulation: Personality traits and health trajectories in the Hawaii longitudinal study of personality and health. Psychology, health & medicine, 21(2), 152-162.
Harada-Shiba, M., Arai, H., Ishigaki, Y., Ishibashi, S., Okamura, T., Ogura, M.,…Miyauchi, K. (2018). Guidelines for diagnosis and treatment of familial hypercholesterolemia 2017. Journal of Atherosclerosis and Thrombosis, 25(8), 751-770.
Heckhausen, J., Brandstätter, V., Fishbach, A., Freund, A. M., Lachman, M. E., & Robert, P. (2021). Goal changes and healthy aging. The Journals of Gerontology: Series B, 76(Supplement_2), S105-S114.
Hollman, G., Olsson, A. G., & Ek, A.-C. (2006). Disease Knowledge and Adherence to Treatment in Patients With Familial Hypercholesterolemia. Journal of Cardiovascular Nursing, 21(2), 103-108.
Horne, J., Madill, J., O’Connor, C., Shelley, J., & Gilliland, J. (2018). A systematic review of genetic testing and lifestyle behaviour change: are we using high-quality genetic interventions and considering behaviour change theory? Lifestyle Genomics, 11(1), 49-63.
Huang, C.-C., Niu, D.-M., & Charng, M.-J. (2022). Genetic analysis in a Taiwanese cohort of 750 index patients with clinically diagnosed familial hypercholesterolemia. Journal of Atherosclerosis and Thrombosis, 29(5), 639-653.
John, O. P., & Srivastava, S. (1999). The Big-Five trait taxonomy: History, measurement, and theoretical perspectives.
Kelley, T. L. (1939). The selection of upper and lower groups for the validation of test items. Journal of educational psychology, 30(1), 17.
Lareyre, O., Gourlan, M., Stoebner-Delbarre, A., & Cousson-Gélie, F. (2021). Characteristics and impact of theory of planned behavior interventions on smoking behavior: a systematic review of the literature. Preventive Medicine, 143, 106327.
Mauch, C. E., Edney, S. M., Viana, J. N. M., Gondalia, S., Sellak, H., Boud, S. J., ... & Ryan, J. C. (2022). Precision health in behaviour change interventions: a scoping review. Preventive Medicine, 163, 107192.
McGowan, M. P., Hosseini Dehkordi, S. H., Moriarty, P. M., & Duell, P. B. (2019). Diagnosis and treatment of heterozygous familial hypercholesterolemia. Journal of the American Heart Association, 8(24), e013225.
Mulder, J. W., Galema-Boers, A. M., de Jong-Verweij, L. M., Hazelzet, J. A., & van Lennep, J. E. R. (2020). The development and first results of a health-related outcomes set in familial hypercholesterolemia (FH) patients: Knowledge is health. Atherosclerosis, 293, 11-17.
Newsom, J. T., Kaplan, M. S., Huguet, N., & McFarland, B. H. (2004). Health behaviors in a representative sample of older Canadians: prevalences, reported change, motivation to change, and perceived barriers. The Gerontologist, 44(2), 193-205.
Nordestgaard, B. G., Chapman, M. J., Humphries, S. E., Ginsberg, H. N., Masana, L., Descamps, O. S., ... & European Atherosclerosis Society Consensus Panel. (2013). Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. European heart journal, 34(45), 3478-3490.
Peltzer, S., Hellstern, M., Gen即使已知ske, A., Jünger, S., Woopen, C., & Albus, C. (2020). Health literacy in persons at risk of and patients with coronary heart disease: a systematic review. Social science & medicine, 245, 112711.
Pranata, S., Wu, S. F. V., Alizargar, J., Liu, J. H., Liang, S. Y., & Lu, Y. Y. (2021). Precision health care elements, definitions, and strategies for patients with diabetes: A literature review. International Journal of Environmental Research and Public Health, 18(12), 6535.
Raal, F. J., Hovingh, G. K., & Catapano, A. L. (2018). Familial hypercholesterolemia treatments: Guidelines and new therapies. Atherosclerosis, 277, 483-492.
Roberts, M. C., Holt, K. E., Del Fiol, G., Baccarelli, A. A., & Allen, C. G. (2024). Precision public health in the era of genomics and big data. Nature Medicine, 30(7), 1865-1873.
Rochefort, C., Hoerger, M., Turiano, N. A., & Duberstein, P. (2019). Big Five personality and health in adults with and without cancer. Journal of health psychology, 24(11), 1494-1504.
Singh, S., & Bittner, V. (2015). Familial hypercholesterolemia—epidemiology, diagnosis, and screening. Current atherosclerosis reports, 17, 1-8.
Tada, H., Kawashiri, M. A., Nohara, A., Sekiya, T., Watanabe, A., & Takamura, M. (2024).
Genetic counseling and genetic testing for familial hypercholesterolemia. Genes, 15(3), 297.
Terry, P. E. (2020). Introducing “Precision Health Promotion”: the convergence of genomics, health education, and lived experience. In (Vol. 34, pp. 235-237): SAGE Publications Sage CA: Los Angeles, CA.
Tokgozoglu, L., & Kayikcioglu, M. (2021). Familial hypercholesterolemia: global burden and approaches. Current cardiology reports, 23, 1-13.
Turiano, N. A., Mroczek, D. K., Moynihan, J., & Chapman, B. P. (2013). Big 5 personality traits and interleukin-6: Evidence for “healthy Neuroticism” in a US population sample. Brain, behavior, and immunity, 28, 83-89.
Versmissen, J., Oosterveer, D. M., Yazdanpanah, M., Defesche, J. C., Basart, D. C., Liem, A. H.,…Kastelein, J. J. (2008). Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. Bmj, 337.
Weidner, G., Sieverding, M., & Chesney, M. A. (2016). The role of self-regulation in health and illness. In (Vol. 21, pp. 135-137): Taylor & Francis.
Wilemon, K. A., Patel, J., Aguilar-Salinas, C., Ahmed, C. D., Alkhnifsawi, M., Almahmeed, W.,…Bernal, L. M. (2020). Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action. JAMA cardiology, 5(2), 217-229.
Ziegelmann, J. P., & Knoll, N. (2015). Future directions in the study of health behavior among older adults. Gerontology, 61(5), 469-476.
Zubielienė, K., Valterytė, G., Jonaitienė, N., Žaliaduonytė, D., & Zabiela, V. (2022). Familial hypercholesterolemia and its current diagnostics and treatment possibilities: a literature analysis. Medicina, 58(11), 1665.

中文參考文獻
王偉存(2017).遊戲回饋機制對玩家自我調節與 遊戲經驗的影響─以音樂節奏遊戲為例.國立交通大學資訊科學與工程研究所碩士論文.
李仁豪, & 鍾芯瑜. (2020). 中文版簡式 [五大人格量表] BFI 的發展. 測驗學刊, 67(4), 271-299.
顏宗義, 吳昱鋭, & 蘇大成. (2021). 家族性高膽固醇血症的診斷與治療新進展. 台灣家庭醫學雜誌, 31(3), 169-186.
-
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99945-
dc.description.abstract研究背景:家族性高膽固醇血症(Familial Hypercholesterolemia, FH)為一種遺傳性血脂異常疾病,若未妥善控制,將顯著提高動脈粥狀硬化與心血管疾病的風險。精準健康諮詢結合基因資訊與個別化衛教,近年被視為具有潛力的策略,可提升疾病認知與促進健康行為改變,然而針對FH異合子族群的實證研究仍相對有限。
研究方法:本研究採單組前後測設計,納入臺灣精準醫療計畫(TPMI)中確認為 FH基因異合子之成人,共105位完成前測,100位完成後測。介入內容為個別化精準健康諮詢,評估疾病知識、服藥遵從性、運動、飲食與抽菸行為等變化,並探討人格特質與自我調節能力是否具有調節效果。
研究結果:介入後,參與者的疾病知識總分由6.2 (±1.7)提升至 7.1 (±1.4),差異具統計意義(p < 0.001)。其中以遺傳風險、HDL 定義與壞膽固醇評估三項知識的改善幅度最大,平均提升約 15%−16%。在血脂控制方面, LDL-C 平均值由 124.4 mg/dL(±40.0)下降至 117.1 mg/dL(±33.6),統計上顯著改善(p = 0.037),顯示介入對血脂控制具有正向影響。健康行為方面,服藥遵從性總分由2.7 (±1.7)下降至2.1 (±1.8)(p = 0.001);每週運動時間平均增加 42 分鐘(p = 0.032);健康飲食得分由 4.3 (±1.9)提升至 4.9 (±1.8)(p = 0.001),整體健康行為呈現正向改變。進一步的迴歸分析顯示,介入成效受到心理特質與背景因素交互作用的影響。在自我調節能力較高的參與者中,隨著年齡增加,行為改善幅度也更明顯(β = 0.01, p = 0.012);具高外向性且有心臟病病史者,亦有較佳的行為改變(β = 0.53, p = 0.027);首次使用藥物且具高開放性特質者的改善效果則最為顯著(β = 1.08, p = 0.008)。
結論:精準健康諮詢有助於提升 FH 異合子個體的疾病知識與部分健康行為,且其成效會受到人格特質與自我調節能力的影響。建議未來介入設計納入心理特質評估與行為支持策略,以強化高風險族群的長期健康管理與健康促進效果。
zh_TW
dc.description.abstractBackground: Familial Hypercholesterolemia (FH) is an inherited lipid disorder that, if not properly managed, significantly increases the risk of atherosclerosis and cardiovascular disease. Precision health counseling, which integrates genetic information with personalized health education, has recently been regarded as a promising strategy to enhance disease understanding and promote health behavior change. However, empirical research focusing on individuals with heterozygous FH remains relatively limited.
Methods: This study adopted a single-group pre-post design and included adults confirmed to be heterozygous for FH-related genetic variants through the Taiwan Precision Medicine Initiative (TPMI). A total of 105 participants completed the pretest and 100 completed the posttest. The intervention consisted of individualized precision health counseling, assessing changes in disease knowledge, medication adherence, exercise, diet, and smoking behaviors. The study also explored whether personality traits and self-regulation ability moderated the intervention’s effects.
Results: After the intervention, participants’ total disease knowledge scores increased significantly from 6.2 (±1.7) to 7.1 (±1.4) (p < 0.001). The greatest improvements were observed in knowledge related to genetic risk, HDL definition, and the evaluation of "bad cholesterol," with average increases of approximately 15%–16%. For lipid control, the average LDL-C level decreased from 124.4 mg/dL (±40.0) to 117.1 mg/dL (±33.6), showing a statistically significant improvement (p = 0.037), indicating a positive effect of the intervention.
Regarding health behaviors, medication adherence scores improved from 2.7 (±1.7) to 2.1 (±1.8) (p = 0.001); average weekly exercise time increased by 42 minutes (p = 0.032); and healthy eating scores rose from 4.3 (±1.9) to 4.9 (±1.8) (p = 0.001), indicating overall positive behavioral changes.
Further regression analysis showed that the intervention’s effectiveness was influenced by the interaction between personality traits and background factors. Among participants with higher self-regulation ability, older age was associated with greater behavioral improvement (β = 0.01, p = 0.012). Participants with high extraversion and a history of heart disease also exhibited better behavior change (β = 0.53, p = 0.027), and those using medication for the first time with high openness traits showed the most significant improvement (β = 1.08, p = 0.008).
Conclusions: Precision health counseling can enhance disease knowledge and improve certain health behaviors in individuals with heterozygous FH. The effectiveness of such interventions may be influenced by personality traits and self-regulation ability. Future intervention designs are recommended to incorporate psychological trait assessments and behavioral support strategies to strengthen long-term health management and health promotion in high-risk populations.
en
dc.description.provenanceSubmitted by admin ntu (admin@lib.ntu.edu.tw) on 2025-09-22T16:05:48Z
No. of bitstreams: 0
en
dc.description.provenanceMade available in DSpace on 2025-09-22T16:05:48Z (GMT). No. of bitstreams: 0en
dc.description.tableofcontents摘要 I
ABSTRACT II
目次 IV
圖次 VI
表次 VII
第一章 緒論 1
第一節 研究背景 1
第二節 研究動機 4
第三節 研究目的 5
第四節 研究假設 5
第五節 名詞界定 5
第二章 文獻回顧 8
第一節 家族性高膽固醇血症概述 8
第二節 疾病知識對健康行為的影響 11
第三節 人格與自我調節在健康行為中的角色 12
第四節 精準健康諮詢的理論與實證 13
第三章 研究方法 15
第一節 研究設計 15
第二節 研究對象 16
第三節 研究工具 17
第四節 分析方法 21
第四章 研究結果 24
第一節 參與者人口學與健康背景分析 24
第二節 疾病知識變化分析 25
第三節 健康行為變化分析 29
第四節 心理特質與行為改變分析 33
第五節 心理特質調節效果分析 37
第六節 知識量表題項表現分析 46
第五章 討論 48
第六章 結論 52
英文參考文獻 53
中文參考文獻 58
附錄 59
附錄A各問卷及量表題數 59
附錄B參與者基本人口學特徵 60
附錄C參與者個人與家族病史背景特徵 61
附錄D參與者疾病知識前測總分分布 62
附錄E人口社經背景變項對疾病知識前測總分之影響分析 63
附錄F研究流程 64
附錄G研究對象篩選流程 65
附錄H研究樣本招募與追蹤流程 66
附錄I研究概念與變項設定 67
附錄J自我調節量表與五大人格量表高低分組依據之百分位數 68
附錄K自我調節量表-簡式中文版使用授權書 69
附錄L中文版簡式五大人格量表使用授權書 70
附錄M台灣人體生物資料庫參與者問卷使用授權書 71
附錄N問卷內容 72
附錄O家族性高膽固醇血症風險相關基因位點一覽 82
-
dc.language.isozh_TW-
dc.subject精準健康諮詢zh_TW
dc.subject家族性高膽固醇血症zh_TW
dc.subject人格特質zh_TW
dc.subject自我調節能力zh_TW
dc.subject健康行為zh_TW
dc.subjectHealth Behavioren
dc.subjectSelf-Regulation Abilityen
dc.subjectPersonality Traitsen
dc.subjectPrecision Health Counselingen
dc.subjectFamilial Hypercholesterolemiaen
dc.title探討精準健康諮詢對家族性高膽固醇血症相關基因異合子個體健康行為改變之影響zh_TW
dc.titleExploring the impact of precision health counseling on health behavior change in individuals heterozygous for familial hypercholesterolemia-associated gene variantsen
dc.typeThesis-
dc.date.schoolyear113-2-
dc.description.degree碩士-
dc.contributor.oralexamcommittee簡穎秀;蕭自宏zh_TW
dc.contributor.oralexamcommitteeYin-Hsiu Chien;Tzu-Hung Hsiaoen
dc.subject.keyword家族性高膽固醇血症,精準健康諮詢,健康行為,自我調節能力,人格特質,zh_TW
dc.subject.keywordFamilial Hypercholesterolemia,Precision Health Counseling,Health Behavior,Self-Regulation Ability,Personality Traits,en
dc.relation.page82-
dc.identifier.doi10.6342/NTU202501925-
dc.rights.note同意授權(限校園內公開)-
dc.date.accepted2025-07-25-
dc.contributor.author-college醫學院-
dc.contributor.author-dept分子醫學研究所-
dc.date.embargo-lift2030-08-01-
顯示於系所單位:分子醫學研究所

文件中的檔案:
檔案 大小格式 
ntu-113-2.pdf
  未授權公開取用
6.13 MBAdobe PDF檢視/開啟
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved